Company Valuation: TMC Life Sciences

Data adjusted to current consolidation scope
Fiscal Period: June 2021 2022 2023 2024 2025 2026
Market Cap 1 1,089 888.4 1,045 1,150 749 783.8
Change - -18.4% 17.65% 10% -34.85% 4.65%
Enterprise Value (EV) 1 1,122 955.7 1,095 1,164 820.3 814
Change - -14.83% 14.63% 6.23% -29.51% -0.77%
P/E 53.9x 21.5x 26.7x 28.3x 208x 45.1x
PBR 1.38x 1.07x 1.21x 1.29x 0.88x 0.9x
PEG - 0x -5.03x 7.96x -2.3x 0x
Capitalization / Revenue 5.42x 3.64x 3.35x 3.32x 2.17x 1.99x
EV / Revenue 5.58x 3.92x 3.52x 3.36x 2.37x 2.07x
EV / EBITDA 31.1x 21.4x 16x 14.5x 21.7x 13.9x
EV / EBIT 43.4x 29.8x 23.3x 20.3x 67.2x 26.8x
EV / FCF -17x -22x -187x 35.3x -29.7x 18.1x
FCF Yield -5.89% -4.55% -0.54% 2.84% -3.37% 5.52%
Dividend per Share 2 0.002215 0.002763 0.004199 0.004898 0.001863 0.005763
Rate of return 0.35% 0.54% 0.7% 0.74% 0.43% 1.28%
EPS 2 0.0116 0.0238 0.0225 0.0233 0.00207 0.009977
Distribution rate 19.1% 11.6% 18.7% 21% 90% 57.8%
Net sales 1 201 243.8 311.6 346.4 345.6 393
EBITDA 1 36.02 44.63 68.43 80.28 37.81 58.47
EBIT 1 25.84 32.1 47.04 57.36 12.21 30.36
Net income 1 20.25 41.39 39.26 40.65 3.606 17.38
Net Debt 1 33.45 67.3 50.36 14.1 71.33 30.15
Reference price 2 0.6250 0.5100 0.6000 0.6600 0.4300 0.4500
Nbr of stocks (in thousands) 1,741,882 1,741,882 1,741,882 1,741,882 1,741,882 1,741,882
Announcement Date 8/24/21 8/23/22 8/22/23 8/21/24 8/26/25 8/14/26
1MYR in Million2MYR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 175M
13.44x0.41x8.51x2.88% 118B
15.49x1.9x9.49x0.68% 99.34B
-277.88x19.12x-326.58x-.--% 56.71B
13.74x1.5x9.07x2.6% 28.56B
23.12x2.58x13.11x1.41% 25.94B
22.82x2.1x12.02x0.92% 25.79B
8.11x1.45x6.59x-.--% 21.52B
30.36x5.52x22.93x2.3% 20.7B
19.57x1.76x8.84x3.55% 18.25B
Average -14.58x 4.04x -26.23x 1.59% 41.51B
Weighted average by Cap. -23.84x 4.01x -35.87x 1.58%

Y-o-Y evolution of P/E

Valuation ratios - P/E - TMC Life Sciences

Historical PBR trend

Valuation ratios - PBR - TMC Life Sciences

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - TMC Life Sciences

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - TMC Life Sciences

  1. Stock Market
  2. Stocks
  3. 0101 Stock
  4. Valuation TMC Life Sciences